These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

223 related items for PubMed ID: 8194612

  • 1. Benefits of continuous physiological pulsatile gonadotropin-releasing hormone therapy in women with polycystic ovarian syndrome.
    Corenthal L, Von Hagen S, Larkins D, Ibrahim J, Santoro N.
    Fertil Steril; 1994 Jun; 61(6):1027-33. PubMed ID: 8194612
    [Abstract] [Full Text] [Related]

  • 2. Endocrine response determines the clinical outcome of pulsatile gonadotropin-releasing hormone ovulation induction in different ovulatory disorders.
    Filicori M, Flamigni C, Meriggiola MC, Ferrari P, Michelacci L, Campaniello E, Valdiserri A, Cognigni G.
    J Clin Endocrinol Metab; 1991 May; 72(5):965-72. PubMed ID: 1902487
    [Abstract] [Full Text] [Related]

  • 3. A randomized controlled study comparing the endocrine effects of pulsatile intravenous gonadotropin-releasing hormone after gonadotropin-releasing hormone agonist pretreatment versus clomiphene citrate in patients with polycystic ovary syndrome.
    Timmerman-van Kessel EC, Cikot RJ, Dargel-Donkers EJ, Zwertbroek W, van Dop PA, Schoot DC.
    Fertil Steril; 2000 Jun; 73(6):1145-8. PubMed ID: 10856472
    [Abstract] [Full Text] [Related]

  • 4. Specific factors predict the response to pulsatile gonadotropin-releasing hormone therapy in polycystic ovarian syndrome.
    Gill S, Taylor AE, Martin KA, Welt CK, Adams JM, Hall JE.
    J Clin Endocrinol Metab; 2001 Jun; 86(6):2428-36. PubMed ID: 11397835
    [Abstract] [Full Text] [Related]

  • 5. Gonadotropin-releasing hormone (GnRH) analog suppression renders polycystic ovarian disease patients more susceptible to ovulation induction with pulsatile GnRH.
    Filicori M, Campaniello E, Michelacci L, Pareschi A, Ferrari P, Bolelli G, Flamigni C.
    J Clin Endocrinol Metab; 1988 Feb; 66(2):327-33. PubMed ID: 3123511
    [Abstract] [Full Text] [Related]

  • 6. The abnormal response of polycystic ovarian disease patients to exogenous pulsatile gonadotropin-releasing hormone: characterization and management.
    Filicori M, Flamigni C, Campaniello E, Valdiserri A, Ferrari P, Meriggiola MC, Michelacci L, Pareschi A.
    J Clin Endocrinol Metab; 1989 Oct; 69(4):825-31. PubMed ID: 2506216
    [Abstract] [Full Text] [Related]

  • 7. Polycystic ovarian syndrome: evidence that flutamide restores sensitivity of the gonadotropin-releasing hormone pulse generator to inhibition by estradiol and progesterone.
    Eagleson CA, Gingrich MB, Pastor CL, Arora TK, Burt CM, Evans WS, Marshall JC.
    J Clin Endocrinol Metab; 2000 Nov; 85(11):4047-52. PubMed ID: 11095431
    [Abstract] [Full Text] [Related]

  • 8. Intravenous administration of pulsatile gonadotropin-releasing hormone in hypothalamic amenorrhea: effects of dosage.
    Santoro N, Wierman ME, Filicori M, Waldstreicher J, Crowley WF.
    J Clin Endocrinol Metab; 1986 Jan; 62(1):109-16. PubMed ID: 3079597
    [Abstract] [Full Text] [Related]

  • 9. The treatment of luteal phase defects with pulsatile infusion of gonadotropin-releasing hormone.
    Loucopoulos A, Ferin M.
    Fertil Steril; 1987 Dec; 48(6):933-6. PubMed ID: 3119374
    [Abstract] [Full Text] [Related]

  • 10. [Ovulation induction with pulsatile gonadotropin-releasing hormone and continuous human menopausal gonadotropin in polycystic ovarian disease].
    Kuroda G.
    Nihon Naibunpi Gakkai Zasshi; 1987 Mar 20; 63(3):247-59. PubMed ID: 3111899
    [Abstract] [Full Text] [Related]

  • 11. Polycystic ovary syndrome: evidence for reduced sensitivity of the gonadotropin-releasing hormone pulse generator to inhibition by estradiol and progesterone.
    Pastor CL, Griffin-Korf ML, Aloi JA, Evans WS, Marshall JC.
    J Clin Endocrinol Metab; 1998 Feb 20; 83(2):582-90. PubMed ID: 9467578
    [Abstract] [Full Text] [Related]

  • 12. Value of subcutaneous and intravenous pulsatile gonadotropin releasing hormone in polycystic ovary disease.
    Saffan DS, Seibel MM.
    J Reprod Med; 1992 Jun 20; 37(6):545-51. PubMed ID: 1619610
    [Abstract] [Full Text] [Related]

  • 13. Evidence for a specific role of GnRH pulse frequency in the control of the human menstrual cycle.
    Filicori M, Flamigni C, Campaniello E, Ferrari P, Meriggiola MC, Michelacci L, Pareschi A, Valdiserri A.
    Am J Physiol; 1989 Dec 20; 257(6 Pt 1):E930-6. PubMed ID: 2514600
    [Abstract] [Full Text] [Related]

  • 14. Mid-follicular phase pulses of inhibin B are absent in polycystic ovarian syndrome and are initiated by successful laparoscopic ovarian diathermy: a possible mechanism regulating emergence of the dominant follicle.
    Lockwood GM, Muttukrishna S, Groome NP, Matthews DR, Ledger WL.
    J Clin Endocrinol Metab; 1998 May 20; 83(5):1730-5. PubMed ID: 9589683
    [Abstract] [Full Text] [Related]

  • 15. Subcutaneous administration of pulsatile gonadotropin-releasing hormone decreases serum follicle-stimulating hormone and luteinizing hormone levels in women with polycystic ovary syndrome: a preliminary study.
    Graña-Barcia M, Liz-Lestón J, Lado-Abeal J.
    Fertil Steril; 2005 May 20; 83(5):1466-72. PubMed ID: 15866586
    [Abstract] [Full Text] [Related]

  • 16. Hypothalamic-pituitary-ovarian response to clomiphene citrate in women with polycystic ovary syndrome.
    Kettel LM, Roseff SJ, Berga SL, Mortola JF, Yen SS.
    Fertil Steril; 1993 Mar 20; 59(3):532-8. PubMed ID: 8458453
    [Abstract] [Full Text] [Related]

  • 17. Induction of ovulation in clomiphene-resistant polycystic ovary syndrome with pulsatile GnRH.
    Tan SL, Farhi J, Homburg R, Jacobs HS.
    Obstet Gynecol; 1996 Aug 20; 88(2):221-6. PubMed ID: 8692506
    [Abstract] [Full Text] [Related]

  • 18. Even after priming with ovarian steroids or pulsatile gonadotropin-releasing hormone administration, naltrexone is unable to induce ovulation in women with functional hypothalamic amenorrhea.
    Couzinet B, Young J, Brailly S, Chanson P, Schaison G.
    J Clin Endocrinol Metab; 1995 Jul 20; 80(7):2102-7. PubMed ID: 7608262
    [Abstract] [Full Text] [Related]

  • 19. Ovulation induction with subcutaneous pulsatile gonadotropin-releasing hormone in various ovulatory disorders.
    Saffan D, Seibel MM.
    Fertil Steril; 1986 Apr 20; 45(4):475-82. PubMed ID: 3082681
    [Abstract] [Full Text] [Related]

  • 20. Comparison of exogenous gonadotropins and pulsatile gonadotropin-releasing hormone for induction of ovulation in hypogonadotropic amenorrhea.
    Martin KA, Hall JE, Adams JM, Crowley WF.
    J Clin Endocrinol Metab; 1993 Jul 20; 77(1):125-9. PubMed ID: 8325934
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.